|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-7-2
|
|
pubmed:abstractText |
For children in the United States who are at high risk for severe respiratory syncytial virus (RSV) infection, the American Academy of Pediatrics (AAP) recommends administering immunoprophylaxis during the RSV season. We present an approach to using surveillance data to help guide application of AAP recommendations for immunoprophylaxis to local patterns of RSV outbreaks.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1098-4275
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
126
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
e116-23
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:20547651-Antibodies, Monoclonal,
pubmed-meshheading:20547651-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:20547651-Antiviral Agents,
pubmed-meshheading:20547651-Child,
pubmed-meshheading:20547651-Child, Preschool,
pubmed-meshheading:20547651-Communicable Disease Control,
pubmed-meshheading:20547651-Databases, Factual,
pubmed-meshheading:20547651-Disease Outbreaks,
pubmed-meshheading:20547651-Female,
pubmed-meshheading:20547651-Humans,
pubmed-meshheading:20547651-Immunization Programs,
pubmed-meshheading:20547651-Infant,
pubmed-meshheading:20547651-Male,
pubmed-meshheading:20547651-Primary Prevention,
pubmed-meshheading:20547651-Respiratory Syncytial Virus, Human,
pubmed-meshheading:20547651-Respiratory Syncytial Virus Infections,
pubmed-meshheading:20547651-Seasons,
pubmed-meshheading:20547651-Sentinel Surveillance,
pubmed-meshheading:20547651-Time Factors,
pubmed-meshheading:20547651-United States
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Use of respiratory syncytial virus surveillance data to optimize the timing of immunoprophylaxis.
|
|
pubmed:affiliation |
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
